Prevention of pancreatic cancer

Stefan Kuroczycki-Saniutycz; Agnieszka Grzeszczuk; Zbigniew Wojciech Zwierz; Paweł Kołodziejczyk; Jakub Szczesiul; Beata Zalewska-Szajda; Krystyna Ościłowicz; Napoleon Waszkiewicz; Krzysztof Zwierz; Sławomir Dariusz Szajda

doi:10.5114/wo.2016.63043

eISSN: 1897-4309
ISSN: 1428-2526

Contemporary Oncology/Współczesna Onkologia

Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

1/2017
vol. 21

Send email

Copy url:

abstract:

Review paper

Prevention of pancreatic cancer

Stefan Kuroczycki-Saniutycz

,

Agnieszka Grzeszczuk

,

Zbigniew Wojciech Zwierz

,

Paweł Kołodziejczyk

,

Jakub Szczesiul

,

Beata Zalewska-Szajda

,

Krystyna Ościłowicz

,

Napoleon Waszkiewicz

,

Krzysztof Zwierz

,

Sławomir Dariusz Szajda

Contemp Oncol (Pozn) 2017; 21 (1): 30-34

DOI: https://doi.org/10.5114/wo.2016.63043

Online publish date: 2017/02/20

View full text Get citation

PlumX metrics:

Pancreatic ductal adenocarcinoma (PDA) accounts for 95% of all pancreatic cancers. About 230,000 PDA cases are diagnosed worldwide each year. PDA has the lowest five-year survival rate as compared to others cancers. PDA in Poland is the fifth leading cause of death after lung, stomach, colon and breast cancer.

In our paper we have analysed the newest epidemiological research, some of it controversial, to establish the best practical solution for pancreatic cancer prevention in the healthy population as well as treatment for patients already diagnosed with pancreatic cancer.

We found that PDA occurs quite frequently but is usually diagnosed too late, at its advanced stage. Screening for PDA is not very well defined except in subgroups of high-risk individuals with genetic disorders or with chronic pancreatitis.

We present convincing, probable, and suggestive risk factors associated with pancreatic cancer, many of which are modifiable and should be introduced and implemented in our society.

keywords:

Prevention of pancreatic cancer

Stefan Kuroczycki-Saniutycz , Agnieszka Grzeszczuk , Zbigniew Wojciech Zwierz , Paweł Kołodziejczyk , Jakub Szczesiul , Beata Zalewska-Szajda , Krystyna Ościłowicz , Napoleon Waszkiewicz , Krzysztof Zwierz , Sławomir Dariusz Szajda

pancreatic ductal adenocarcinoma (PDA), pancreatic cancer, prophylactic, incidence, prevalence, risk factors

Stefan Kuroczycki-Saniutycz

,

Agnieszka Grzeszczuk

,

Zbigniew Wojciech Zwierz

,

Paweł Kołodziejczyk

,

Jakub Szczesiul

,

Beata Zalewska-Szajda

,

Krystyna Ościłowicz

,

Napoleon Waszkiewicz

,

Krzysztof Zwierz

,

Sławomir Dariusz Szajda